Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Our team

Latest publications

CHCHD2 links mitochondrial dysfunction and α-synuclein misfolding in Parkinson's disease.

Journal article

Narendra D. and Ryan BJ., (2026), Trends Neurosci

Heritable maintenance of chromatin modifications confers transcriptional memory of interferon-γ signaling.

Journal article

Mikulski P. et al, (2025), Nat Struct Mol Biol, 32, 1255 - 1267

Formation of seeding-competent α-synuclein aggregates in parkin-deficient iPSC-derived human neurons.

Journal article

Schmidt SI. et al, (2025), NPJ Parkinsons Dis, 11

Recent developments in gene therapy for Parkinson's disease.

Journal article

Szunyogh S. et al, (2025), Mol Ther, 33, 2052 - 2064

Tau depletion in human neurons mitigates Aβ-driven toxicity.

Journal article

Ng B. et al, (2024), Mol Psychiatry, 29, 2009 - 2020

A fluid-walled microfluidic platform for human neuron microcircuits and directed axotomy.

Journal article

Nebuloni F. et al, (2024), Lab Chip, 24, 3252 - 3264

CRISPRi: a way to integrate iPSC-derived neuronal models.

Journal article

Franks SNJ. et al, (2024), Biochem Soc Trans, 52, 539 - 551